NMX Research and Solutions is a leading brand offering innovative biophysics-based solutions to the pharmaceutical and biotech industry. With a focus on boosting drug-discovery projects, NMX provides a range of services to accelerate the development of novel drugs. Their expertise lies in four key areas: CRO, Biotech, Biophysics Platform, and uNMR.

By leveraging their deep knowledge and cutting-edge technology, NMX enables clients to launch and advance their drug discovery programs efficiently. Their services cover a wide range of areas, including fragment screening, ligand binding studies, compound behavior analysis, target binding site identification, protein expression, protein purification, bioanalytical characterization, clone design, and more. NMX also specializes in primary structure verification, early analoging, docking, virtual screening, and structure-based drug design.

With a commitment to delivering quality and timely results, NMX helps clients achieve their goals while saving time and reducing costs. Discover the seeds for your future drug leads by partnering with NMX Research and Solutions today. Contact them at their headquarters in Laval, Québec, Canada